Browse > Article
http://dx.doi.org/10.4062/biomolther.2011.19.1.009

Neuroadaptations Involved in Long-Term Exposure to ADHD Pharmacotherapies: Alterations That Support Dependence Liability of These Medications  

Dela Pena, Ike C. (Uimyung Research Institute for Neuroscience, Sahmyook University)
Ahn, Hyung-Seok (Uimyung Research Institute for Neuroscience, Sahmyook University)
Shin, Chan-Young (Center for Geriatric Neuroscience Research, Institute of Biomedical Science and Technology, Konkuk University)
Cheong, Jae-Hoon (Uimyung Research Institute for Neuroscience, Sahmyook University)
Publication Information
Biomolecules & Therapeutics / v.19, no.1, 2011 , pp. 9-20 More about this Journal
Abstract
Repeated administration of addictive drugs causes cellular and molecular changes believed to be the mechanism of pro-addictive behaviors. Neuroadaptations also take place with repeated administration of amphetamine, methylphenidate and atomoxetine, drugs for Attention Deficit Hyperactivity Disorders (ADHD), and it is speculated that these changes may serve as markers to demonstrate the dependence liability of these therapies. In this review, we enumerate the neuroadaptive changes in molecules associated with neuronal signaling and plasticity, as well as neuronal morphology wrought by repeated administration of ADHD medications. We provide the current perspective on the dependence liability of these therapies, and also suggest of some factors that need to be considered in future investigations, so that what is drawn from animal studies would be better consolidated with those known clinically.
Keywords
Neuroadaptations; Amphetamine; Methylphenidate; Atomoxetine; Dependence liability;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 2  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Kalivas, P. W. and Duffy, T. (1998) Repeated cocaine administrationalters extracellular glutamate levels in the ventral tegmental area.J. Neurochem. 70, 1497-1502.
2 Kalivas, P. W. and O’Brien, C. (2008) Drug addiction as a pathology ofstaged neuroplasticity. Neuropsychopharmacol. 33, 166-180.   DOI
3 Kankaanpaa, A., Meririnne, E. and Seppala, T. (2002) 5-HT3 receptorantagonist MDL 72222 attenuates cocaine- and mazindol-, but notmethylphenidate-induced neurochemical and behavioral effects inthe rat. Psychopharmacol. (Ber) 159, 341-350.   DOI
4 Grimm, J. W., Lu, L., Hayashi, T., Hope, B. T., Su, T. P. and Shaham,Y. (2003) Time-dependent increases in brain-derived neurotrophicfactor protein levels within the mesolimbic dopamine system afterwithdrawal from cocaine: implications for incubation of cocainecraving. J. Neurosci. 23, 742-747.
5 Guillin, O., Diaz, J., Carroll, P., Griffon, N., Schwartz, J. C. and Sokoloff,P. (2001) BDNF controls dopamine D3 receptor expression andtriggers behavioural sensitization. Nature. 411, 86-89.   DOI
6 Heal, D. J., Cheetham, S. C. and Smith, S. L. (2009) The neuropharmacologyof ADHD drugs in vivo: Insights on effi cacy and safety.Neuropharmacol. 57, 7-8.
7 Hechtman, L. and Greenfi eld, B. (2003) Long-term use of stimulants inchildren with attention defi cit hyperactivity disorder: safety, efficacy,and long-term outcome. Paediatr. Drugs 5, 787-794.   DOI   ScienceOn
8 Heil, S. H., Holmes, H. W., Bickel, W. K., Higgins, S. T., Badger, G. J.,Laws, H. F. and Faries, D. E. (2002) Comparison of the subjective,physiological, and psychomotor effects of atomoxetine and methylphenidatein light drug users. Drug Alcohol Depend. 67, 149-156.   DOI
9 Herges, S. and Taylor, D. A. (1998) Involvement of serotonin in themodulation of cocaine-induced locomotor activity in the rat. Pharmacol.Biochem. Behav. 59, 595-611.   DOI
10 Himelstein, J., Newcorn, J. H. and Halperin, J. M. (2000) The neurobiologyof attention-deficit hyperactivity disorder. Front. Biosci. 5,D461-D478.   DOI
11 Hiroi, N., Brown, J. R., Haile, C. N., Ye, H., Greenberg, M. E. andNestler, E. J. (1997) FosB mutant mice: Loss of chronic cocaineinduction of Fos-related proteins and heightened sensitivity to cocaine'spsychomotor and rewarding effects. Proc. Natl. Acad. Sci.USA. 94, 10397-10402.   DOI
12 Hooks, M. S., Jones, G. H., Neill, D. B. and Justice, J. B. (1991) Individualdifferences in amphetamine sensitization: dose-dependenteffects. Pharmacol. Biochem. Behav. 41, 203-210.
13 Faraone, S. V. and Biederman, J. (2005) What is the prevalence ofadult ADHD? Results of a population screen of 966 adults. J. Atten.Dissord. 9, 384-391.   DOI
14 Faraone, S. V., Wigal, S. B. and Hodgkins, P. (2007) Forecastingthree-month outcomes in a laboratory school comparison of mixedamphetamine salts extended release (Adderall XR) and atomoxetine(Strattera) in school-aged children with ADHD. J. Atten. Disord.11, 74-82.   DOI
15 Fumagalli, F., Cattaneo, A., Caffi no, L., Ibba, M., Racagni, G., Carboni,E., Gennarelli, M. and Riva, M. A. (2010) Sub-chronic exposure toatomoxetine up-regulates BDNF expression and signalling in thebrain of adolescent spontaneously hypertensive rats: Comparisonwith methylphenidate. Pharmacol. Res. 62, 523-529.   DOI
16 Gao, W. Y., Lee, T. H., King, G. R. and Ellinwood, E. H. (1998) Alterationsin baseline activity and quinpirole sensitivity in putative dopamineneurons in the substantia nigra and ventral tegmental areaafter withdrawal from cocaine pretreatment. Neuropsychophamacol.18, 222-232.   DOI
17 Gardier, A. M., Moratalla, R., Cuellar, B., Sacerdote, M., Guibert, B.,Lebrec, H. and Graybiel, A. M. (2000) Interaction between the serotoninergicand dopaminergic systems in d-fenfl uramine-inducedactivation of cfos and jun B genes in rat striatal neurons. J. Neurochem.74, 1363-1373.
18 Yang, P., Behrang, A., Swann, A. and Nachum, D. (2003) Strain differencesin the behavioral responses of male rats to chronicallyadministered methylphenidate. Brain Res. 971, 139-152.   DOI
19 Yano, M. and Steiner, H. (2005a) Methylphenidate (Ritalin) inducesHomer 1a and zif 268 expression in specific corticostriatal circuits.Neurosci. 132, 855-865.   DOI
20 Yano, M. and Steiner, H. (2005b) Topography of methylphenidate(Ritalin)-induced gene regulation in the striatum: differential effectson c-fos, substance P and opioid peptides. Neuropsychopharmacol.30, 901-915.   DOI
21 Gasior, M., Bergman, J., Kallman, M. J. and Paronis, C. A. (2005) Evaluationof the reinforcing effects of monoamine reuptake inhibitorsunder a concurrent schedule of food and i.v. drug delivery in rhesusmonkeys. Neuropsychopharmacol. 30, 758-764.
22 Goldman-Rakic, P. S. (1996) Cellular basis of working memory. Neuron14, 477-485.
23 Grimes, C. A. and Jope, R. S. (2001) The multifaceted roles of glycogensynthase kinase 3beta in cellular signaling. Prog. Neurobiol.65, 391-426.   DOI
24 Chase, T. D., Carrey, N., Brown, R. E. and Wilkinson, M. (2005a) Methylphenidateregulates c-fos and fosB expression in multiple regionsof the immature rat brain. Brain Res. Dev. Brain Res. 156, 1-12.   DOI   ScienceOn
25 Chase, T. D., Carrey, N., Brown, R. E. and Wilkinson, M. (2005b)Methylphenidate differentially regulates c-fos and fosB expressionin the developing rat striatum. Dev. Brain Res. 157, 181-191.   DOI
26 Chase, T., Carrey, N., Soo, E. and Wilkinson, M. (2007) Methylphenidateregulates activity regulated cytoskeletal associated but notbrain-derived neurotrophic factor gene expression in the developingrat striatum. Neurosci. 144, 969-984.   DOI
27 Commons, K. G. (2010) Neuronal pathways linking substance P todrug addiction and stress. Brain Res. 1314, 175-182.   DOI
28 Zhang, X. F., Hu, X. T., White, F. J. and Wolf, M. E. (1997) Increased responsiveness of ventral tegmental area dopamine neurons to glutamateafter repeated administration of cocaine or amphetamine istransient and selectively involves AMPA receptors. J. Pharmacol.Exp. Ther. 281, 699-706.
29 Yano, M., Beverley, J. A. and Steiner, H. (2006) Inhibition of methylphenidate-induced gene expression in the striatum by local blockadeof D1 receptors: Interhemispheric effects. Neurosci. 140, 699-709.   DOI   ScienceOn
30 Yano, M. and Steiner, H. (2007) Methylphenidate and cocaine:thesame effects on gene regulation. Trends in Pharmacol Sci. 28,588-596.   DOI   ScienceOn
31 White, F. J., Hu, X. T., Zhang, X. F. and Wolf, M. E. (1995) Repeatedadministration of cocaine or amphetamine alters neuronal responsesto glutamate in the mesoaccumbens dopamine system. J. Pharmacol.Exp. Ther. 273, 445-454.
32 White, F. J. and Wolf, M. E. (1991) Psychomotor stimulants. In TheBiological Basis of Drug Tolerance and Dependence (J. A. Pratt,Ed.), pp. 153-197. Academic Press, London,   DOI
33 Everitt, B. J. and Robbins,T. W. (2005) Neural systems of reinforcementfor drug addiction: From actions to habits to compulsion. Nat.Neurosci. 8, 1481-1489.   DOI
34 Cotterly, L., Beverley, J. A., Yano, M. and Steiner, H. (2007) Dysregulationof gene induction in corticostriatal circuits after repeated methylphenidatetreatment in adolescent rats: Differential effects on zif268 and homer 1a. Eur. J. Neurosci. 25, 3617-3628.   DOI
35 Daunais, J. B. and McGinty, J. F. (1994) Acute and chronic cocaineadministration differentially alters striatal opioid and nuclear transcriptionfactor mRNAs. Synapse 18, 35-45.   DOI
36 de la Pena, I. C., Ahn, H. S., Choi, J. Y., Shin, C. Y., Ryu, J. H. andCheong, J. H. (2011) Methylphenidate self-adminstration and conditionedplace preference in an animal model of attention deficithyperactivity disorder-the spontaneously hypertensive rat. Behav.Pharmacol. 22, 31-39.   DOI   ScienceOn
37 Evans, C., Blackburn, D. and Butt, P. (2004) Use and abuse of methylphenidatein attention-deficit hyperactivity disorder. CPJ/RPC 137,30-33.
38 Biederman, J., Wigal, S. B., Spencer, T. J., McGough, J. J. and Mays,D. A. (2006) A post hoc subgroup analysis of an 18-day randomizedcontrolled trial comparing the tolerability and effi cacy of mixedamphetamine salts extended release and atomoxetine in school-agegirls with attention-deficit/hyperactivity disorder. Clin. Ther. 28,280-293.   DOI
39 Bonci, A., Bernardi, G., Grillner, P. and Mercuri, N. B. (2003) The dopamine-containing neuron: maestro or simple musician in the orchestraof addiction. Trends Pharmacol. Sci. 24, 172-177.   DOI
40 Bramham, C. R. and Messaoudi, E. (2005). BDNF function in adultsynaptic plasticity: the synaptic consolidation hypothesis. Prog.Neurobiol. 76, 99-125.   DOI
41 Willuhn, I., Sun, W. and Steiner, H. (2003) Topography of cocaine-inducedgene regulation in the rat striatum: relationship to corticalinputs and role of behavioral context. Eur. J. Neurosci. 17, 1053-1066.   DOI
42 Wigal, S. B., McGough, J. J., McCracken, J. T., Biederman, J., Spencer,T. J., Posner, K. L., Wigal, T. L., Kollins, S. H., Clark, T. M.,Mays, D. A., Zhang, Y. and Tulloch, S. J. (2005) A laboratory schoolcomparison of mixed amphetamine salts extended release (AdderallXR) and atomoxetine (Strattera) in school-aged children withattention deficit/hyperactivity disorder. J. Atten. Disord. 9, 275-289.   DOI
43 Wilens, T. E., Faraone, S. V., Biederman, J. and Gunawardene, S.(2003) Does stimulant therapy of attention-deficit/hyperactivity disorderbeget later substance abuse? A meta-analytic review of theliterature. Pediatrics 111, 179-185.   DOI   ScienceOn
44 Wilens, T. E., Adler, L. A., Adams, J., Sgambati, S., Rotrosen, J., Sawtelle,R., Utzinger, L. and Fusillo, S. (2008) Misuse and diversion ofstimulants prescribed for ADHD: a systematic review of the literature.J Am. Acad. Child. Adolesc. Psychiatry 47, 21-31.   DOI
45 Xiao, B., Tu, J. C. and Worley. P. (2000) Homer: a link between neuralactivity and glutamate receptor function. Curr. Opin. Neurobiol. 10,370-374.   DOI
46 Xue, C. J., Ng, J. P., Li, Y. and Wolf, M. E. (1996) Acute and repeatedsystemic amphetamine administration: Effects on extracellular glutamate,aspartate, and serine levels in rat ventral tegmental areaand nucleus accumbens. J. Neurochem. 67, 352-363.   DOI
47 Volkow, N. D., Fowler, J. S., Wang, G. J., Ding, Y. S. and Gatley, S. J.,(2002a) Role of dopamine in the therapeutic and reinforcing effectsof methylphenidate in humans: results from imaging studies. Eur.J. Neuropsychopharmacol. 12, 557-566.   DOI
48 Carlezon, W. A. Jr. and Nestler, E. J. (2002) Elevated levels of GluR1in the midbrain: a trigger for sensitization to drugs of abuse? TrendsNeurosci. 25, 610-615.   DOI
49 Brandon, C. L. and Steiner, H. (2003) Repeated methylphenidatetreatment in adolescent rats alters gene regulation in the striatum.Eur. J. Neurosci. 18, 1584-1592.   DOI
50 Bymaster, F. P., Katner, J. S., Nelson, D. L., Hemrick-Luecke, S. K.,Threlkeld, P. G., Heiligenstein, J. H., Morin, S. M., Gehlert, D. R.and Perry, K. W. (2002) Atomoxetine increases extracellular levelsof norepinephrine and dopamine in prefrontal cortex of rat: apotential mechanism for efficacy in attention deficit/hyperactivitydisorder. Neuropsychopharmacol. 27, 699-711.   DOI
51 Chao, J. and Nestler, E. J. (2004) Molecular neurobiology of drug addiction.Annu. Rev. Med. 55, 113-132.   DOI
52 Chase, T. D., Brown, R. E., Carrey, N., Wilkinson, M., Chase, T. D.,Brown, R. E., Carrey, N. and Wilkinson, M. (2003) Daily methylphenidateadministration attenuates c-fos expression in the striatum ofprepubertal rats. Neuroreport 14, 769-772.   DOI
53 Andersen, S. L., Arvanitogiannis, A., Pliakas, A. M., LeBlanc, C. andCarlezon, W. A. Jr. (2002) Altered responsiveness to cocaine inrats exposed to methylphenidate during development. Nat. Neurosci.5, 13-14.   DOI
54 Arnsten A. F. (2006) Stimulants: therapeutic actions in ADHD. Neuropsychopharmacol.31, 2376-2383.   DOI
55 Askenasy, E. P., Taber, K. H., Yang, P. B. and Dafny, N. (2007) Methylphenidate(Ritalin): behavioral studies in the rat. Intern. J. Neurosci. 117, 757-794.   DOI   ScienceOn
56 Wee, S. and Woolverton, W. L. (2004) Evaluation of the reinforcingeffects of atomoxetine in monkeys: comparison to methylphenidateand desipramine. Drug and Alc. Dep. 75, 271-276.   DOI
57 Volkow, N. D., Wang, G. J., Fowler, J. S., Logan, J., Gatley, S. J.,Wong, C., Hitzemann, R. and Pappas, N. R. (1999) Reinforcing effectsof psychostimulants in humans are associated with increasesin brain dopamine and occupancy of D(2) receptors. J. Pharmacol.Exp. Ther. 291, 409-415.   DOI
58 Volkow, N. D., Wang, G. J., Fowler, J. S., Thanos, P. P., Logan, J.and Gatley, S. J., (2002b) Brain DA D2 receptors predict reinforcingeffects of stimulants in humans: replication study. Synapse 46,79-82.   DOI
59 Walker, P. D., Capodilupo J. G., Wolf W. A. and Carlock, L. R. (1996)Preprotachykinin and preproenkephalin mRNA expression withinstriatal subregions in response to altered serotonin transmission.Brain Res. 732, 25-35.   DOI
60 White, F. J. and Kalivas, P. W. (1998) Neuroadaptations involved inamphetamine and cocaine addiction. Drug and Alc. Dep. 51, 141-153.   DOI
61 White, F. J. and Wang, R. Y. (1984) Electrophysiological evidence forA10 dopamine autoreceptor subsensitivity following chronic d-amphetaminetreatment. Brain Res. 309, 283-292.   DOI
62 White, F. J., Hu, X. T., Henry, D. J. and Zhang, X. F. (1995) Neurophysiologicalalterations in the mesocorticolimbic dopamine systemduring repeated cocaine administration. In The Neurobiologyof Cocaine: Cellular and Molecular Mechanisms (R. P. Jr. Hammer,Ed.), pp. 95-115. CRC Press, Boca Raton.
63 Toda, S., Shen, H. W., Peters, J., Cagle, S. and Kalivas, P. W. (2006)Cocaine increases actin cycling: Effects in the reinstatement modelof drug seeking. J. Neurosci. 26, 1579.   DOI
64 Beitner-Johnson, D., Guitart, X. and Nestler, E. J. (1992) Neurofi lamentproteins and the mesolimbic dopamine system: common regulationby chronic morphine and chronic cocaine in the rat ventraltegmental area. J. Neurosci. 12, 2165-2176.
65 Banerjee, P. S., Aston, J., Khundakar, A. A. and Zetterstrom, T. S.(2009) Differential regulation of psychostimulant-induced gene expressionof brain derived neurotrophic factor and the immediateearlygene arc in the juvenile and adult brain Eur. J. Neurosci. 29,465-476.   DOI
66 Barkley, R. A., Fischer, M., Smallish, L. and Fletcher, K. (2003) Doesthe treatment of attention-defi cit/hyperactivity disorder with stimulantscontribute to drug use/abuse? A 13-year prospective study.Pediatrics 111, 97-109.   DOI
67 Barron, E., Yang, P. B., Swann, A. C. and Dafny, N. (2009) Adolescentand adult male spontaneous hyperactive rats (SHR) respond differentlyto acute and chronic methylphenidate (Ritalin). Int. J. Neurosci.119, 40-58.   DOI
68 Berke, J. D. and Hyman, S. E. (2000) Addiction, dopamine, and themolecular mechanisms of memory. Neuron 25, 515-532.   DOI
69 Biederman, J. and Faraone, S. V. (2005) Attention-deficit hyperactivitydisorder. Lancet. 366, 237-248.   DOI
70 Todtenkopf, M. S., Parsegian, A., Naydenov, A., Neve, R. L., Konradi,C. and Carlezon, Jr. W. A. (2006) Brain reward regulated by AMPAreceptor subunits in nucleus accumbens shell. J. Neurosci. 26,11665-11669.   DOI
71 Unal, C. T., Beverley, J. A., Willuhn, I. and Steiner, H. (2009) Longlastingdysregulation of gene expression in corticostriatal circuitsafter repeated cocaine treatment in adult rats: effects on zif 268and homer 1a. Eur J. Neurosci. 21, 1615-1626.   DOI
72 van der Kooij, M. A. and Glennon, J. C. (2007) Animal models concerningthe role of dopamine in attention-deficit hyperactivity disorder.Neurosci. Biobehav. Rev. 31, 597-618.   DOI
73 Vanderschuren, L. J. and Kalivas, P. W. (2000) Alterations in dopaminergicand glutamatergic transmission in the induction and expression of behavioral sensitization: A critical review of preclinicalstudies. Psychopharmacol. 151, 99-120.   DOI
74 Vendruscolo, L. F., Izidio, G. S. and Takahashi, R. N. (2009) Drug reinforcementin a rat model of attention deficit/hyperactivity disorderthespontaneously hypertensive rat (SHR). Curr. Drug Abuse Rev.2, 177-183.   DOI
75 Vezina, P. (2004) Sensitization of midbrain dopamine neuron reactivityand the self-administration of psychomotor stimulant drugs. Neurosci.Biobehav. Rev. 27, 827-839.   DOI   ScienceOn
76 Volkow N. D. and Swanson, J. M. (2003) Variables that affect the clinicaluse and abuse of methylphenidate in the treatment of ADHD.Am. J. Psychiatry. 160, 1909-1918.   DOI
77 Striplin, C. D. and Kalivas, P. W. (1993) Robustness of G proteinchanges in cocaine sensitization shown with immunoblotting. Synapse14, 10-15.   DOI
78 Amini, B., Yang, P. B., Swann, A. C. and Dafny, N. (2004) Differentiallocomotor responses in male rats from three strains to acute methylphenidate.Int. J. Neurosci. 114, 1063-1083.   DOI   ScienceOn
79 Ackerman, J. M. and White, F. J. (1990) A10 somatodendritic dopamineautoreceptor sensitivity following withdrawal from repeatedcocaine treatment. Neurosci. Lett. 117, 181-187.   DOI
80 Adriani, W., Leo, D., Greco, D., Rea, M., di Porzio, U., Laviola, G.and Perrone-Capano, C. (2006) Methylphenidate administration toadolescent rats determines plastic changes in reward-related behaviorand striatal gene expression. Neuropsychopharmacol. 31,1946-1956.   DOI
81 Andersen, S. L., LeBlanc, C. J. and Lyss, P. J. (2001) Maturationalincreases in c-fos expression in the ascending dopamine systems.Synapse 41, 345-350.   DOI
82 Szumlinski, K., Ary, A. W. and Lominac K. D. (2008) Homers regulatedrug-induced neuroplasticity: Implications for addiction. Biochem.Pharmacol. 75, 112-133.   DOI
83 Swanson, J., McBurnett, K., Christian, D. and Wigal, T. (1995) Stimulantmedications and the treatment of children with ADHD. In Advancesin Clinical Psychology (T. Ollendick, R. Prinz, Eds.), pp.265-322. Plenum Press, New York, NY.
84 Swanson, J. M., Sergeant, J. A., Taylor, E., Sonuga-Barke, E. J. S.,Jensen, P. S. and Cantwell, D. P. (1998) Attention defi cit disorderand hyperkinetic disorder. Lancet. 351, 429-433.   DOI
85 Swanson, C. J., Perry, K. W., Koch-Krueger, S., Katner, J., Svensson,K. A. and Bymaster, F. P. (2006) Effect of the attention deficit/hyperactivitydisorder drug atomoxetine on extracellular concentrationsof norepinephrine and dopamine in several brain regions of the rat.Neuropharmacol. 50, 755-760.   DOI
86 Teicher, M. H., Andersen, S. L. and Hostetter, J. C. (1995) Evidence fordopamine receptor pruning between adolescence and adulthood instriatum but not nucleus accumbens. Dev. Brain. Res. 89, 167-172.   DOI
87 Teicher, M. H., Andersen, S. L. and Hostetter, J. C. (1995) Evidence fordopamine receptor pruning between adolescence and adulthood instriatum but not nucleus accumbens. Dev. Brain. Res. 89, 167-172.   DOI
88 Teicher, M. H., Anderson, C. M., Polcari, A., Glod, C. A., Maas, L. C.and Renshaw, P. F. (2000). Functional deficits in basal ganglia ofchildren with attention-deficit hyperactivity disorder shown withfunctional magnetic resonance imaging relaxometry. Nat. Med. 6,470-473.   DOI
89 Thomas, U. (2002) Modulation of synaptic signalling complexes byHomer proteins. J. Neurochem. 81, 407-413.   DOI
90 Segal, D. S. and Kuczenski, R. (1999) Escalating dose-binge treatmentwith methylphenidate: role of serotonin in the emergent behavioralprolife profile. J. Pharmacol. Exp. Ther. 291, 19-30.
91 Segal, D. S. and Kuczenski, R. (1987) Individual differences in responsiveness to single and repeated amphetamine administration:behavioral characteristics and neurochemical correlates. J. Pharmacol.Exp. Ther. 242, 917-926.
92 Self, D. W. and Nestler, E. J. (1995) Molecular mechanisms of drugreinforcement and addiction. Annu. Rev. Neurosci. 18, 463-495.   DOI
93 Sontag, T., Tucha, O., Walitza, S. and Lange, K. W. (2010) Animalmodels of attention defi cit/hyperactivity disorder (ADHD): a criticalreview. ADHD Atten. Def. Hyp. Disord. 2, 1-20.   DOI
94 Sorg, B. A., Davidson, D. L., Kalivas, P. W. and Prasad, B. M. (1997)Repeated daily cocaine alters subsequent cocaine-induced increaseof extracellular dopamine in the medial prefrontal cortex. J.Pharmacol. Exp. Ther. 281, 54-61.
95 Spangler, R., Zhou, Y., Maggos, C. E., Schlussman, S. D., Ho, A. andKreek, M. J. (1997) Prodynorphin, proenkephalin and kappa opioidreceptor mRNA responses to acute ‘‘binge’’ cocaine. Brain Res.Mol. Brain Res. 44, 139-142.   DOI
96 Starr, H. L. and Kemner, J. (2005) Multicenter, randomized, open-labelstudy of OROS methylphenidate versus atomoxetine: treatmentoutcomes in African American children with ADHD. J. Natl. Med.Assoc. 97, 11S-16S.
97 Steiner, H. and Gerfen, C. R. (1993) Cocaine-induced c-fos messengerRNA is inversely related to dynorphin expression in striatum. J.Neurosci. 13, 5066-5081.
98 Steiner, H. and Gerfen, C. R. (1998) Role of dynorphin and enkephalinin the regulation of striatal output pathways and behavior. Exp.Brain Res. 123, 60-76.   DOI
99 Robinson, T. E. and Kolb, B. (2004) Structural plasticity associatedwith exposure to drugs of abuse. Neuropharmacol. 47, 33-46.   DOI
100 Steketee, J. D. (2005) Cortical mechanisms of cocaine sensitization.Crit. Rev. Neurobiol. 17, 69-86.   DOI   ScienceOn
101 Robinson, T. E. and Berridge, K. C. (1993) The neural basis of drugcraving: an incentive-sensitization theory of addiction. Brain Res.Rev. 18, 247-291.   DOI
102 Robinson, T. E. and Kolb, B. (1999) Alterations in the morphology ofdendrites and dendritic spines in the nucleus accumbens and prefrontalcortex following repeated treatment with amphetamine orcocaine. Eur. J. Neurosci. 11, 1598-1604.   DOI
103 Russell, V. A., Sagvolden, T. and Johansen, E. B. (2005) Animal modelsof attention-defi cit hyperactivity disorder. Behav. Brain Funct.1, 9.   DOI
104 Sagvolden, T. and Sergeant, J. A. (1998) Attention defi cit/hyperactivitydisorder--from brain dysfunctions to behaviour. Behav. Brain Res.94, 1-10.   DOI
105 Sagvolden, T., Russell, V. A., Aase, H., Johansen, E. B. and Farshbaf,M. (2005a) Rodent models of attention-deficit/hyperactivity disorder.Biol. Psychiatry 57, 1239-1247.   DOI
106 Sagvolden, T., Johansen, E. B., Aase, H. and Russell, V. A. (2005b) A dynamic developmental theory of Attention- Deficit/Hyperactivity Disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav. Brain. Sci. 28, 397-419.
107 Sagvolden, T., Johansen, E. B., Wøien, G., Walaas, S. I., Storm-Mathisen,J., Bergersen, L. H., Hvalby, O., Jensen, V., Aase, H., Russell,V. A., Killeen, P. R., Dasbanerjee, T., Middleton, F. A. and FaraoneS. V. (2009) The spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strain. Neuropharmacol.57, 619-626.   DOI   ScienceOn
108 Pierce, R. C., Bell, K., Duffy, P. and Kalivas, P. W. (1996) Repeated cocaineaugments excitatory amino acid transmission in the nucleusaccumbens only in rats having developed behavioral sensitization.J. Neurosci. 16, 1550-1560.
109 See, R. E. and Kalivas, P. W. (2008) Neuroscience of substance abuseand dependence. In Kaplan & Sadock's Comprehensive Textbookof Psychiatry (B. J. Sadock, V. A. Sadock, P. Ruiz, Eds.), pp. 387-393. Williams & Wilkins, Lippincott.
110 Pierce, R. C. and Kalivas, P. W. (1997) A circuitry model of the expressionof behavioral sensitization to amphetamine-like psychostimulants.Brain Res. Rev. 25, 192-216.   DOI   ScienceOn
111 Prasad, S. and Steer, S. (2008) Switching from neurostimulant therapyto atomoxetine in children and adolescents with attention-deficithyperactivity disorder: clinical approaches and review of currentavailable evidence. Ped. Drugs 10, 39-47.   DOI
112 Pulvirenti, L., Maldonado-Lopez, R. and Koob, G. F. (1992) NMDA receptorsin the nucleus accumbens modulate intravenous cocainebut not heroin self-administration in the rat. Brain Res. 594, 327-330.   DOI
113 Pulvirenti, L., Berrier, R., Kreifeldt, M. and Koob, G. F. (1994) Modulationof locomotor activity by NMDA receptors in the nucleus accumbenscore and shell regions of the rat. Brain Res. 664, 231-236.   DOI
114 Rat Genome Database: 2008 (http://rgd.mcw.edu).
115 Reid, M. S. and Berger, S. P. (1996) Evidence for sensitization ofcocaine-induced mucleus accumbens glutamate release. Neuroreport7, 1325-1329.   DOI
116 Robinson, L. M., Sclar, D. A., Skaer, T. L. and Galin, R. S. (1999) Nationaltrends in the prevalence of attention-defi cit/hyperactivity disorderand the prescribing of methylphenidate among school-agechildren: 1990-1995. Clin. Pediatr. (Phila). 38, 209-217.   DOI
117 Newcorn, J. H., Kratochvil, C. J., Allen, A. J., Casat, C. D., Ruff, D. D.,Moore, R. J. and Michelson, D. (2008) Atomoxetine and osmoticallyreleased methylphenidate for the treatment of attention deficithyperactivity disorder: acute comparison and differential response.Am. J. Psych. 165, 721-730.   DOI
118 Robinson, T. E. and Kolb, B. (1997) Persistent structural modifi cationsin nucleus accumbens and prefrontal cortex neurons produced byprevious experience with amphetamine. J. Neurosci. 21, 8491-8497.
119 Nestler E. J. (2001) Molecular basis of long-term plasticity underlyingaddiction. Nat. Rev Neurosci. 2, 119-128.   DOI
120 Nestler, E. J., Terwilliger, R. Z., Walker, J. R., Sevarino, K. A. and Duman,R. S. (1990) Chronic cocaine treatment decreases levels ofthe G protein subunits $Gi{\alpha}$ and Goα in discrete regions of rat brain.J. Neurochem. 55, 1079-1082.   DOI
121 Norrholm, S. D., Bibb, J. A., Nestler, E. J. Ouimet, C. C., Taylor. J.R. and Greengard, P. (2003) Cocaine-induced proliferation of dendriticspines in the nucleus accumbens is dependent on the activityof cyclin-dependent kinase-5. Neurosci. 26, 12308-12313.
122 Okamoto, K. and Aoki, K. (1963) Development of a strain of spontaneouslyhypertensive rats. Jpn. Circ. J. 27, 282-293.   DOI   ScienceOn
123 Pandolfo, P., Pamplona, F., Prediger, R. and Takahashi, R. (2007) Increasedsensitivity of adolescent spontaneously hypertensive rats,an animal model of attention defi cit hyperactivity disorder, to the locomotorstimulation induced by cannabinoid receptor agonist WIN55,212-2. Eur. Jour. Pharmacol. 563, 141-148.   DOI   ScienceOn
124 Pandolfo, P., Vendruscolo, L., Sordi, R. and Takahashi, R. (2009)Cannabinoid-induced conditioned place preference in the spontaneouslyhypertensive rat-an animal model of attention deficit hyperactivitydisorder. Psychopharmacol. 205, 319-326.   DOI
125 Lin, J. S., Hou, Y. and Jouvet, M. (1996) Potential brain neuronal targetsfor amphetamine-, methylphenidate-, and modafi nil-inducedwakefulness, evidenced by c-fos immunocytochemistry in the cat.Proc. Natl. Acad. Sci. USA. 93, 14128-14133.   DOI
126 Piazza, P. V., Deminie`re, J. M., Le Moal, M. and Simon, H. (1989)Factors that predict individual vulnerability to amphetamine self-administration,Science 245, 1511-1513.   DOI
127 Li, Y., Kolb, B. and Robinson, T. E. (2003) The location of persistentamphetamine-induced changes in the density of dendritic spineson medium spiny neurons in the nucleus accumbens and caudate-putamen.Neuropsychopharmacol. 28, 1082-5.
128 Lile, J. A., Stoops, W. W., Durell, T. M., Glaser, P. E. and Rush, C.R. (2006) Discriminative-stimulus, self-reported, performance andcardiovascular effects of atomoxetine in methylphenidate-trainedhumans. Exp. Clin. Psychopharmacol. 14, 136-147.   DOI
129 Lu, B. and Figurov, A. (1997) Role of neurotrophins in synapse developmentand plasticity. Rev. Neurosci. 8, 1-12.   DOI
130 Maganti, R. (2004) Neuroscience of psychoactive substance abuseand dependence. Annals of Pharmacother. 38, 1-264.
131 Mandyam, C. D., Wee, S., Crawford, E. F., Eisch, A. J., Richardson, H.N. and Koob, G. F. (2008) Varied access to intravenous methamphetamineself-administration differentially alters adult hippocampalneurogenesis. Biol. Psych. 64, 958-965.   DOI
132 Meredith, G. E., Callen, S. and Scheuer D. A. (2002) Brain-derivedneurotrophic factor expression is increased in the rat amygdale,piriform cortex and hypothalamus following repeated amphetamineadministration. Brain Res. 949, 218-227.   DOI
133 Koob, G. F. and LeMoal, M. (2001) Drug addiction, dysregulation ofreward, and allostasis. Neuropsychopharmacol. 24, 97-129.   DOI   ScienceOn
134 Mijnster, M. J., Galis-de Graaf Y. and Voorn, P. (1998) Serotonergicregulation of neuropeptide and glutamic acid decarboxylase mRNAlevels in the rat striatum and globus pallidus: studies with fl uoxetineand DOI. Brain Res. Mol. Brain Res. 54, 64-73.   DOI
135 Nestler, E. J. (1996) Under siege: the brain on opiates. Neuron. 16,897-900.   DOI
136 Koob, G. F., Sanna, P. P. and Bloom, F. E. (1998) Neuroscience of addiction.Neuron 21, 467-476.   DOI
137 Kopnisky, K. L. and Hyman, S. E. (2002) Molecular and cellular biologyof addiction. In Neuropsychopharmacology: The Fifth Generationof Progress (K. L. Davis, D. Charney, J. T. Coyle, C. Nemeroff,Eds.), pp. 1368-1379. Lippincott Williams and Wilkins, Philadelphia.
138 Kostrzewa, R. M., Reader, T. A. and Descarries, L. (1998) Serotoninneural adaptations to ontogenetic loss of dopamine neurons in ratbrain. J. Neurochem. 70, 889-898.
139 Korsching, S., Turgeon, S. M., Pollack, A. E. and Fink, J. S. (1993)The neurotrophic factor concept: a reexamination. J. Neurosci. 13,2739-2748.
140 Kuczenski, R. and Segal, D. S. (1997) Effects of methylphenidate onextracellular dopamine, serotonin, and norepinephrine: comparisonwith amphetamine. J. Neurochem. 68, 2032-2037.
141 Kuczenski, R. and Segal, D. S. (2002) Exposure of adolescent rats tooral methylphenidate: preferential effects on extracellular norepinephrineand absence of sensitization and cross-sensitization tomethamphetamine. J. Neurosci. 22, 7264-7271.
142 Katusic, S. K., Barbaresi, W. J., Colligan, R. C., Weaver, A. L., Leibson,C. L. and Jacobsen, S. J. (2005) Psychostimulant treatmentand risk for substance abuse among young adults with a historyof attentiondefi cit/hyperactivity disorder: a population-based, birthcohort study. J. Child. Adolesc. Psychopharmacol. 15, 764-776.   DOI   ScienceOn
143 Kuczenski, R. and Segal, D. S. (2005) Stimulant actions in rodents: implicationsfor attention-defi cit/hyperactivity disorder treatment andpotential substance abuse. Biol. Psychiatry. 57, 1391-1396.   DOI
144 Lagace, D. C., Yee, J. K., Bolanos, C. A. and Eisch, A. J. (2006) Juvenileadministration of methylphenidate attenuates adult hippocampalneurogenesis. Biol. Psychiatry 60, 1121-1130.   DOI
145 Lambert, N. M. and Hartsong, C. S. (1998) Prospective study of tobaccosmoking and substance dependencies among samples ofADHD and non-ADHD participants. J. Learn. Diabil. 31, 533-544.   DOI
146 Kemner, J. E., Starr, H. L., Ciccone, P. E., Hooper-Wood, C. G. andCrockett, R. S. (2005) Outcomes of OROSmethylphenidate comparedwith atomoxetine in childrenwith ADHD: a multi-center, randomizedprospective study. Adv. Ther. 22, 498-512.   DOI
147 Kim, H. J., Park, S. H., Kyeong M. K., Ryu, J. H., Cheong, J. H. andShin, C. Y. (2008) Ever increasing number of animal model systemsfor attention defi cit/hyperactivity disorder: attention please.Biomol. and Ther. 16, 312-319.   DOI
148 Kim, Y., Teylan, M. A., baron, M., Sands, A., Nairn, A. C. and Greengard,P. (2008) Methylphenidate-induced dendritic spine formationand fosB expression in nucleus accumbens. PNAS. 106, 2915-2920.
149 Kiyatkin, E. A. and Rebec, G. V. (1996) Dopaminergic modulation ofglutamate-induced excitations of neurons in the neostriatum andnucleus accumbens of awake, unrestrained rats. J. Neurophysiol.75, 142-153.
150 Koda, K., Ago, Y., Cong, Y., Kita, Y., Takuma, K. and Matsuda, T.(2010) Effects of acute and chronic administration of atomoxetineand methylphenidate on extracellular levels of noradrenaline, dopamineand serotonin in the prefrontal cortex and striatum of mice.J. Neurochem. 114, 259-270.
151 Kollins, S. H., MacDonald, E. K. and Rush, C. R. (2001) Assessingthe abuse potential of methylphenidate in nonhuman and humansubjects: review. Pharmacol. Biochem. Behav. 68, 611-627.   DOI   ScienceOn
152 Kollins, S. H. (2003) Comparing the abuse potential of methylphenidateversus other stimulants: a review of available evidence andrelevance to the ADHD patient. J. Clin. Psych. 64, 14-18.   DOI
153 Hope, B., Kosofsky, B., Hyman, S. E. and Nestler, E. J. (1992) Regulationof immediate early gene expression and AP-1 binding in therat nucleus accumbens by chronic cocaine. Proc. Natl. Acad. Sci.USA. 89, 5764-5768.   DOI
154 Horner, K. A., Adams, D. H., Hanson, G. R. and Keefe, K. A. (2005)Blockade of stimulant-induced preprodynorphin mRNA expressionin the striatal matrix by serotonin depletion. Neurosci. 131, 67-77.   DOI
155 Hyman, S. E. (1996) Addiction to cocaine and amphetamine. Neuron16, 901-904.   DOI
156 Hyman, S. E. and Malenka, R. C. (2001) Addiction and the brain: theneurobiology of compulsion and its persistence. Nat. Rev. Neurosci.2, 695-703.   DOI
157 Jasinski, D. R., Faries, D. E., Moore, R. J., Schuh, L. M. and Allen, A. J.(2008) Abuse liability assessment of atomoxetine in a drug-abusingpopulation. Drug Alcohol Depend. 95, 140-146.   DOI
158 Kalivas, P. W. (1993) Neurotransmitter regulation of dopamine neuronsin ventral tegmental area. Brain Res. Rev. 18, 75-113.   DOI   ScienceOn